Expert consensus of immunemodulatory therapy of chronic obstructive pulmonary disease

Title: Expert consensus of immunemodulatory therapy of chronic obstructive pulmonary disease
Edition: Original
Classification: Experts consensus
Field: Treatment
Countries and regions: China
Guidelines users: Chinese pulmonary and critical care medicine specialists and community doctors
Evidence classification method: Evidence grading and recommendation intensity system of Oxford evidence-based medicine center
Development unit: 北京大学第三医院
Registration time: 2022-05-13
Registration number: IPGRP-2022CN267
Purpose of the guideline: Promote th clinical practice of immunomodulatory therapy in Chinese COPD patients.